Drugs / Peanut Flour
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02203799 | Jul 2014 → Feb 2020 | — | Baylor College of Medicine | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT03251508 | Jan 2018 → Nov 2021 | food allergy | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1/2 | NCT01274429 | Dec 2010 → Nov 2015 | food allergy | University of North Carolina, Chapel Hill | Terminated | No outcome recorded Stop: Business |
| Phase 22 trials · 1 met primary | ||||||
| Phase 2 | NCT03345160 | Apr 2018 → Oct 2020 | — | Johns Hopkins University | Completed | Met primary |
| Phase 2 | NCT01814241 | Apr 2013 → Dec 2015 | food allergy | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT03881696 | Jul 2019 → Mar 2023 | food allergy | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Met primary |
| Phase not applicable2 trials | ||||||
| — | NCT05165329 | Nov 2021 → Sep 2024 | food allergy | Chinese University of Hong Kong | Unknown | No outcome recorded |
| — | NCT01324401 | Mar 2011 → May 2016 | food allergy | Massachusetts General Hospital | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT01750879 Comparator | Aug 2013 → Jul 2017 | food allergy | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT00932282 Comparator | Jul 2009 → Aug 2015 | — | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peanut flour | “Salvage Peanut Oral Immunotherapy Study is a single-arm, open label trial of peanut flour oral immunotherapy (OIT) administered for 6 months followed by introduction of dietary...” NCT03251508 ↗8“The peanut protein is ingested in the form of peanut flour. Peanut flour will be given in small pre-measured soufflé cups containing the amount of peanut flour that needs to be...” NCT02203799 ↗ “Peanut flour taken by mouth, given every day. Dose ranges from 0.2mg of peanut flour to 8000mg of peanut flour during the maintenance phase.” NCT00932282 ↗ “Open label orally ingested peanut flour with maintenance dose of 1450mg” NCT01814241 ↗ |
| Known as | Peanut | “Multi-allergen OIT will be any of the following drug products: peanut, milk, egg, wheat, cashew, hazelnut, and walnut (all food protein flours).” NCT03881696 ↗ |
| Modality | Protein / enzyme biologic | “The study also looks at the safety and immune system effects of the investigational study product, peanut protein.” NCT01274429 ↗ |
| Route | Oral | “Peanut flour taken by mouth” NCT00932282 ↗ |